184 related articles for article (PubMed ID: 38785916)
1. TRAF1 from a Structural Perspective.
Jang H; Kim S; Kim DY; Han JH; Park HH
Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785916
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of TRAF1 TRAF domain and its implications in the TRAF1-mediated intracellular signaling pathway.
Kim CM; Choi JY; Bhat EA; Jeong JH; Son YJ; Kim S; Park HH
Sci Rep; 2016 May; 6():25526. PubMed ID: 27151821
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for TANK recognition by TRAF1 revealed by the crystal structure of TRAF1/TANK complex.
Kim CM; Jeong JH; Son YJ; Choi JH; Kim S; Park HH
FEBS Lett; 2017 Mar; 591(5):810-821. PubMed ID: 28155233
[TBL] [Abstract][Full Text] [Related]
4. Structure of TRAF Family: Current Understanding of Receptor Recognition.
Park HH
Front Immunol; 2018; 9():1999. PubMed ID: 30214450
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Target Recognition by TRAF1 and TRAF2.
Kim CM; Park HH
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326186
[TBL] [Abstract][Full Text] [Related]
6. TRAF1 and its biological functions.
Lee SY; Choi Y
Adv Exp Med Biol; 2007; 597():25-31. PubMed ID: 17633014
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.
Zheng C; Kabaleeswaran V; Wang Y; Cheng G; Wu H
Mol Cell; 2010 Apr; 38(1):101-13. PubMed ID: 20385093
[TBL] [Abstract][Full Text] [Related]
8. Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation.
Henkler F; Baumann B; Fotin-Mleczek M; Weingärtner M; Schwenzer R; Peters N; Graness A; Wirth T; Scheurich P; Schmid JA; Wajant H
J Biol Chem; 2003 Aug; 278(31):29216-30. PubMed ID: 12709429
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of Nine TRAF Genes in Yellow Catfish (
You SL; Jiang XX; Zhang GR; Ji W; Ma XF; Zhou X; Wei KJ
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176078
[TBL] [Abstract][Full Text] [Related]
10. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
[TBL] [Abstract][Full Text] [Related]
11. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.
Takeuchi M; Rothe M; Goeddel DV
J Biol Chem; 1996 Aug; 271(33):19935-42. PubMed ID: 8702708
[TBL] [Abstract][Full Text] [Related]
12. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas.
Conti A; Ageunnouz M; La Torre D; Cardali S; Angileri FF; Buemi C; Tomasello C; Iacopino DG; D'Avella D; Vita G; Tomasello F
J Neurosurg; 2005 Nov; 103(5):873-81. PubMed ID: 16304992
[TBL] [Abstract][Full Text] [Related]
13. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS
J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling.
Xie P; Hostager BS; Munroe ME; Moore CR; Bishop GA
J Immunol; 2006 May; 176(9):5388-400. PubMed ID: 16622006
[TBL] [Abstract][Full Text] [Related]
15. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
[TBL] [Abstract][Full Text] [Related]
16. Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase.
Kim HH; Lee DE; Shin JN; Lee YS; Jeon YM; Chung CH; Ni J; Kwon BS; Lee ZH
FEBS Lett; 1999 Jan; 443(3):297-302. PubMed ID: 10025951
[TBL] [Abstract][Full Text] [Related]
17. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Martinez RL; Alkan S
Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
[TBL] [Abstract][Full Text] [Related]
18. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
[TBL] [Abstract][Full Text] [Related]
19. TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis.
Wang Q; Gao G; Zhang T; Yao K; Chen H; Park MH; Yamamoto H; Wang K; Ma W; Malakhova M; Bode AM; Dong Z
Cancer Res; 2018 Jul; 78(14):3982-3994. PubMed ID: 29748372
[TBL] [Abstract][Full Text] [Related]
20. TRAF-mediated TNFR-family signaling.
Arron JR; Walsh MC; Choi Y
Curr Protoc Immunol; 2002 Nov; Chapter 11():11.9D.1-11.9D.14. PubMed ID: 18432871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
